US 11136577
Methods and compositions for inhibiting PMP22 expression
granted A61KA61K31/7088A61K9/0019
Quick answer
US patent 11136577 (Methods and compositions for inhibiting PMP22 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/7088, A61K9/0019, A61P, A61P25/02